ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt (NYSE: MNK) today announced the commercial launch of PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.
Help employers find you! Check out all the jobs and post your resume.
